Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'.
Hassan MZ. et al, (2025), The Lancet regional health. Southeast Asia, 33
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
Kasbergen LMR. et al, (2025), The Lancet Infectious Diseases
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
Sigfrid L. et al, (2025), The Lancet Infectious Diseases
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Pesonel E. et al, (2025), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Ebola disease: bridging scientific discoveries and clinical application.
Rojek A. et al, (2024), The Lancet. Infectious diseases
Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)
Duvignaud A. et al, (2024), Journal of the Pediatric Infectious Diseases Society, 13, 513 - 522
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002
Group sequential designs for clinical trials when the maximum sample size is uncertain
Yarahmadi A. et al, (2024), Statistics in Medicine, 43, 4667 - 4683
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials.
Vale C. et al, (2024), The lancet. Diabetes & endocrinology, 12, 735 - 747
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Randremanana RV. et al, (2024), Trials, 25
Community Involvement in an Outbreak-One Year on for Mpox.
Cheyne A. et al, (2024), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 79, 278 - 280
Nipah virus disease: what can we do to improve patient care?
Hassan MZ. et al, (2024), The Lancet Infectious Diseases, 24, e463 - e471
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591
Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.
Gonçalves BP. et al, (2024), Epidemiology (Cambridge, Mass.), 35, 368 - 371
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Chan XHS. et al, (2024)
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Faust SN. et al, (2024), The Lancet Child & Adolescent Health, 8, 190 - 200
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Sandercock P. et al, (2024), Nature Communications, 15
Mpox: The alarm went off. Have we gone back to sleep?
Olliaro P. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011871 - e0011871
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.
Bourner J. et al, (2024), PloS one, 19
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet Diabetes & Endocrinology, 11, 905 - 914
The burden and dynamics of hospital-acquired SARS-CoV-2 in England
Cooper BS. et al, (2023), Nature, 623, 132 - 138
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity.
Swets MC. et al, (2023), Nature communications, 14
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Pairo-Castineira E. et al, (2023), Nature, 619, E61 - E61
Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs
Rigby I. et al, (2023), The Lancet Infectious Diseases, 23, e240 - e252
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Pairo-Castineira E. et al, (2023), Nature, 617, 764 - 768
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet, 401, 1499 - 1507
Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.
Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.
Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
Randomised controlled trials for mpox in endemic countries.
Rojek A. et al, (2023), The Lancet. Infectious diseases, 23
Facilitating participation in clinical trials during pregnancy.
Vousden N. et al, (2023), BMJ (Clinical research ed.), 380
Engaging the community during PLATINUM: A randomised controlled trial of tecovirimat in non-hospitalised mpox patients
Cheyne A. et al, (2023), TROPICAL MEDICINE & INTERNATIONAL HEALTH, 28, 388 - 388
MOSAIC: A cohort study of human mpox virus disease.
Pesonel E. et al, (2023), Wellcome open research, 8
An evaluation of global Chikungunya clinical management guidelines: A systematic review
Webb E. et al, (2022), eClinicalMedicine, 54, 101672 - 101672
Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial.
Peto L. et al, (2022), Advances in biological regulation, 86
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases
Hassoun-Kheir N. et al, (2022), Clinical Microbiology and Infection, 28, 1528 - 1532